Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

42,70 -0,56 (-1,29%) Al cierre: 03:00PM CST

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Building 7
Yard 79, Science and Technology Park Shuangying West Road Changping District
Beijing 102200
China
86 10 6074 8199
https://www.sun-novo.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 1370

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Yujing Liu	GM & Director	N/A	N/A	1982
Mr. Lingyang Zhao	CFO, Board Secretary & Director	N/A	N/A	1988
Ms. Yan Shao	Deputy General Manager	N/A	N/A	1978
Mr. Xinquan Tuo	Deputy General Manager	N/A	N/A	1971
Mr. Guangtao Hao	Deputy GM & Core Technician	N/A	N/A	1980
Mr. Huan Luo	Deputy GM & Core Technician	N/A	N/A	1984
Weijun Yan	In Charge of Accounting	N/A	N/A	N/A
Ms. Wang Mingjuan	Core Technical Staff	N/A	N/A	1976
Mr. Xie Daosheng	Core Technical Staff	N/A	N/A	1985
Mr. Yuanbo Li	Core Technical Staff	N/A	N/A	1979

Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en CNY.

Descripción

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Gobierno corporativo

El ISS Governance QualityScore de Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.